{"organizations": [], "uuid": "1dade7ed473b7c8ff9cb69e33d6ca74b4160bd60", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-iovance-biotherapeutics-announces/brief-iovance-biotherapeutics-announces-pricing-of-its-public-offering-of-150-million-of-common-stock-idUSASB0C2BS", "country": "US", "domain_rank": 408, "title": "BRIEF-Iovance Biotherapeutics Announces Pricing Of Its Public Offering Of $150 Million Of Common Stock", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-25T15:18:00.000+02:00", "replies_count": 0, "uuid": "1dade7ed473b7c8ff9cb69e33d6ca74b4160bd60"}, "author": "", "url": "https://www.reuters.com/article/brief-iovance-biotherapeutics-announces/brief-iovance-biotherapeutics-announces-pricing-of-its-public-offering-of-150-million-of-common-stock-idUSASB0C2BS", "ord_in_thread": 0, "title": "BRIEF-Iovance Biotherapeutics Announces Pricing Of Its Public Offering Of $150 Million Of Common Stock", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-iovance biotherapeutics", "sentiment": "negative"}, {"name": "million of common stock reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "iovance biotherapeutics inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 25, 2018 / 1:20 PM / in 12 minutes BRIEF-Iovance Biotherapeutics Announces Pricing Of Its Public Offering Of $150 Million Of Common Stock Reuters Staff \nJan 25 (Reuters) - Iovance Biotherapeutics Inc: \n* IOVANCE BIOTHERAPEUTICS, INC. ANNOUNCES PRICING OF ITS PUBLIC OFFERING OF $150 MILLION OF COMMON STOCK \n* IOVANCE BIOTHERAPEUTICS INC - PRICING OF UNDERWRITTEN PUBLIC OFFERING OF 13 MILLION SHARES OF COMMON STOCK AT A PUBLIC OFFERING PRICE OF $11.50 PER SHARE Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-25T15:18:00.000+02:00", "crawled": "2018-01-25T15:38:19.014+02:00", "highlightTitle": ""}